GO
Loading...

Big pharma by the numbers

Tuesday, 29 Jul 2014 | 8:02 AM ET

What we are seeing is innovation is not dead, says Barbara Ryan, FTI Consulting, discussing Pfizer and Merck's second quarter results and big Pharma drug trends.